Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Case Briefing
U.S. Attorney Files Drug Counterfeiting Complaint
In a criminal complaint filed December 5 in the U.S. District Court in Kansas City, MO, a Florida man was charged with selling counterfeit Lipitor', a prescription drug manufactured and distributed by Pfizer Ireland Pharmaceuticals and Pfizer Inc. The complaint alleges that Julio Cesar Cruz sold 203 bottles of Lipitor 10 mg tablets, with each bottle containing 5000 tablets, to G&K Pharma LLC, a Florida firm licensed to sell wholesale drugs in Missouri. Some of the tablets in each bottle tested by the Office of Criminal Investigations for the FDA, however, were counterfeit, ie, not manufactured or distributed by Pfizer. Further forensic analysis indicated that the bottles contained a mixture of counterfeit Lipitor and illegally diverted foreign-manufactured Lipitor. The complaint also alleges that Cruz manipulated and falsified the drugs' pedigree.
The DOJ's Corporate Enforcement Policy: One Year Later
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Use of Deferred Prosecution Agreements In White Collar Investigations
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
How AI Has Affected PR
When we consider how the use of AI affects legal PR and communications, we have to look at it as an industrywide global phenomenon. A recent online conference provided an overview of the latest AI trends in public relations, and specifically, the impact of AI on communications. Here are some of the key points and takeaways from several of the speakers, who provided current best practices, tips, concerns and case studies.
The DOJ's New Parameters for Evaluating Corporate Compliance Programs
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.